nuclivision, a Gent, Belgium-based medtech startup, raised €5M in Seed funding.
Backers included HERAN Partners, LUMO Labs, and imec.istart future fund.
The company intends to use the funds to accelerate the commercialization of our PET image enhancement software, Nuclarity, across Europe and the US.
Led by CEO Maarten Larmuseau, nuclivision is advancing a software platform that makes it possible to perform scans with less radiation and in a shorter time, without compromising on image quality.
The startup is currently in the final phase of regulatory approval for the software platform. As soon as this is completed, the strategic entry into the European market will follow and into the American market later this year.
FinSMEs
28/04/2025